ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
132.628,32
-0,29%
S&P 500
5.744,02
-0,02%
US Dollar vs BRL
5,4351
-0,06%
Bitcoin
65.859,21
1,05%
Brent Oil
71,625
0,95%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Eli Lilly and Co (LLY)

  7. Eli Lilly and Co (LLY) Notícias

LLY

Eli Lilly (LLY)

Eli Lilly and Co
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:LLY
DataHoraFonteTítuloCódigoCompanhia
25/09/202407:45PR Newswire (US)New data show Lilly's EBGLYSS™ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitisNYSE:LLYEli Lilly and Co
24/09/202407:00PR Newswire (US)Lilly's Kisunla™ (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer's DiseaseNYSE:LLYEli Lilly and Co
18/09/202417:19Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
17/09/202418:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
13/09/202417:07PR Newswire (US)FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic DermatitisNYSE:LLYEli Lilly and Co
12/09/202406:30PR Newswire (US)Lilly expands manufacturing footprint in Ireland with $1.8 billion investmentNYSE:LLYEli Lilly and Co
10/09/202412:57PR Newswire (US)With once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetesNYSE:LLYEli Lilly and Co
10/09/202412:18PR Newswire (US)Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetesNYSE:LLYEli Lilly and Co
10/09/202407:02IH Market NewsApple Loses EU Dispute; Google’s $2.7 Billion Fine Upheld; Oracle Shares Surge 9%NYSE:LLYEli Lilly and Co
09/09/202408:03Edgar (US Regulatory)Form 8-K - Current reportNYSE:LLYEli Lilly and Co
09/09/202407:45PR Newswire (US)Lilly appoints Lucas Montarce as executive vice president and chief financial officerNYSE:LLYEli Lilly and Co
05/09/202407:45PR Newswire (US)In a first-of-its-kind fixed dose study, once weekly insulin efsitora alfa leads to A1C reduction similar to daily insulinNYSE:LLYEli Lilly and Co
04/09/202407:00PR Newswire (US)Lilly and EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countriesNYSE:LLYEli Lilly and Co
28/08/202406:50IH Market NewsHigh Volatility Expected in Nvidia Report, Ambarella Soars 20%, Hertz Strengthens Board, Apple Cuts JobsNYSE:LLYEli Lilly and Co
27/08/202407:45PR Newswire (US)Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesityNYSE:LLYEli Lilly and Co
26/08/202417:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
26/08/202409:58IH Market NewsIBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without AstronautsNYSE:LLYEli Lilly and Co
22/08/202411:00PR Newswire (US)Lilly to participate in Morgan Stanley 22nd Annual Global Healthcare ConferenceNYSE:LLYEli Lilly and Co
21/08/202409:12IH Market NewsWalmart Sells JD.com Stake, Microchip Suffers Cyberattack, Union Pacific Warns of Strike in Canada, and Latest NewsNYSE:LLYEli Lilly and Co
20/08/202407:45PR Newswire (US)Tirzepatide reduced the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweightNYSE:LLYEli Lilly and Co
16/08/202417:15PR Newswire (US)Lilly announces retirement of Marschall S. Runge from its Board of DirectorsNYSE:LLYEli Lilly and Co
16/08/202409:51Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NYSE:LLYEli Lilly and Co
16/08/202409:38PR Newswire (US)Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel DiseaseNYSE:LLYEli Lilly and Co
15/08/202407:05IH Market NewsGoogle Forced to Modify Play Store, Apple Innovates, Victoria’s Secret Hires CEO, Mars Buys KellanovaNYSE:LLYEli Lilly and Co
15/08/202407:05IH Market NewsGoogle Mandated to Modify Play Store, Apple Innovates, Victoria’s Secret Hires CEO, Mars Buys KellanovaNYSE:LLYEli Lilly and Co
13/08/202417:31Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:LLYEli Lilly and Co
13/08/202409:00PR Newswire (US)Lilly opens state-of-the-art research and development center in the Boston SeaportNYSE:LLYEli Lilly and Co
12/08/202417:51Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:LLYEli Lilly and Co
09/08/202406:50IH Market NewsUS Futures Climb Following Thursday’s Rally, Oil Prices SteadyNYSE:LLYEli Lilly and Co
08/08/202417:36IH Market NewsPullback By Jobless Claims Contributes To Rally On Wall StreetNYSE:LLYEli Lilly and Co
 Apresentando as notícias mais relevantes sobre:NYSE:LLY

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
HAGA3
HAGA ON
BOV
PRIO3
PETRORIO ON
BOV
AZEV4
AZEVEDO PN
BOV
COGN3
COGNA ON
BOV
AMBP3
Ambipar Participacoes e ... ON
BOV
RNEW4
RENOVA PN
BOV
AZUL4
AZUL PN
BOV
PDGR3
PDG REALT ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
GFSA3
GAFISA ON
BOV
TPIS3
TRIUNFO PART ON
BOV
RAIZ4
Raizen S.A PN
BOV
RCSL4
RECRUSUL PN
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
OIBR3
OI ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados